Importantly, the proportion of activated NK cell subsets (CD56+/CD94+, CD3-/CD69+) was significantly greater in glioblastoma patients at diagnosis, as compared to healthy controls (Kruskal Wallis test, *p < 0.05) (Figures 4D,E). The gene discussed is NCAM1; the disease is glioblastoma.